Full Press Release Details
SAN DIEGO , Nov. 6, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the Credit Suisse Healthcare Conference in Scottsdale, Arizona on Wednesday, November 13, 2013 at 5:30 p.m. ET / 2:30 p.m. PT . Gregory I. Frost , President and Chief Executive Officer, Halozyme Therapeutics, will provide a corporate overview.
The presentation will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com , and a recording will be made available for 90 days following the event. To access the live webcast, please log on to Halozyme's website approximately 15 minutes prior to the presentation to register and download any necessary audio software.
Investor Contact: Schond Greenway Halozyme Therapeutics 858-704-8352 [email protected]
Media Contact: Nurha Hindi Hill + Knowlton Strategies 818-522-8411 [email protected]
SOURCE Halozyme Therapeutics, Inc.